|1.||Casati, A: 14 articles (07/2007 - 01/2000)|
|2.||Ilfeld, Brian M: 13 articles (01/2015 - 06/2002)|
|3.||Fanelli, G: 10 articles (07/2007 - 01/2000)|
|4.||Borgeat, Alain: 9 articles (11/2014 - 02/2002)|
|5.||Loland, Vanessa J: 7 articles (01/2015 - 11/2008)|
|6.||Mariano, Edward R: 6 articles (11/2014 - 03/2007)|
|7.||Fredrickson, Michael J: 6 articles (09/2012 - 11/2009)|
|8.||Casati, Andrea: 6 articles (11/2004 - 04/2002)|
|9.||Fanelli, Guido: 5 articles (08/2015 - 04/2002)|
|10.||Kehlet, H: 5 articles (05/2015 - 11/2008)|
05/01/2009 - "Continuous ropivacaine perineural infusion (n = 15) produced a statistically and clinically significant reduction in average pain (median [10th-90th percentile]) on POD 1 compared with saline infusion (n = 15) after initial ropivacaine bolus (0.0 [0.0-5.0] versus 3.0 [0.0-6.0], respectively; P < 0.001). "
04/01/2006 - "The pain assessments upon movement of the operated joint were significantly greater after 24 hours in the group receiving a single dose of ropivacaine to block the sciatic nerve. "
11/01/2004 - "We found a statistically significant improvement in pain scores at 2 and 4 hours in the group allocated to receive a patent drain and ropivacaine. "
11/01/2010 - "Continuous supraclavicular BPB with 0.2% ropivacaine at 6 ml x hr(-1) is effective for the pain management after shoulder surgery and is not an excess dose."
03/04/2010 - "The continuous infusion of ropivacaine is effective in controlling pain for a wide variety of surgical procedures and reducing opioid adverse effects and dependency. "
09/07/2010 - "CFNA with ropivacaine 0.2% is more effective in controlling postoperative pain than CIA and CFNB is an effective regional component of a multimodal analgesic strategy after TKA."
01/01/2002 - "Ropivacaine 1 mg x ml(-1) showed less efficacy while the use of ropivacaine 3 mg x ml(-1) was associated with a higher incidence of motor block with minimal improvement in postoperative pain relief."
01/01/2014 - "Ropivacaine CWI is effective for postoperative pain management in a wide range of surgical procedures."
01/01/2014 - "We investigated the efficacy of combining local anaesthetic infiltration of ropivacaine with pulmonary recruitment manoeuvre on postoperative pain following diagnostic hysteroscopy and laparoscopy. "
07/01/2005 - "Ropivacaine flush almost eliminated the postoperative pain and discomfort. "
|3.||Wounds and Injuries (Trauma)
09/10/2013 - "Surgical wound infusion with ropivacaine is safe and effective. "
03/01/2013 - "The aim of this prospective, randomized, double-blind, placebo controlled trial was to evaluate the safety and efficacy of continuous ropivacaine infusion of into the sternal wound. "
12/01/2012 - "This trial sought to determine the efficacy of ropivacaine wound infusion following laparoscopic colonic surgery. "
12/01/2010 - "The analgesic efficacy of continuous wound instillation with ropivacaine after open hepatic surgery."
09/01/2004 - "The postoperative analgesic efficacy of wound instillation with ropivacaine 0.1% versus ropivacaine 0.2%."
06/01/1999 - "We conclude that 1% ropivacaine is a suitable agent for single injection peribulbar anaesthesia for cataract surgery."
03/01/2007 - "Deep-topical anaesthesia with ropivacaine or lidocaine was equally effective in providing anaesthesia with sufficient quality for cataract surgery."
12/01/2011 - "Cataract surgery complications: an in vitro model of toxic effects of ropivacaine and lidocaine."
06/01/2006 - "Levobupivacaine (0.5%) has better anaesthetic properties with respect to 0.75% ropivacaine and is well-suited for peribulbar block in cataract surgery."
06/01/2006 - "Efficacy and comparison of 0.5% levobupivacaine with 0.75% ropivacaine for peribulbar anaesthesia in cataract surgery."
|5.||Hallux Valgus (Bunion)
09/01/2006 - "Eighty-three patients scheduled to undergo acromioplasty or hallux valgus surgery received an interscalene (n = 40) or popliteal (n = 43) peripheral nerve block with 30 ml ropivacaine, 0.5%. "
11/01/2012 - "Forty patients scheduled for ambulatory percutaneous hallux valgus repair were randomly assigned to two anesthesia and analgesia blocks: foot infiltration achieved by a mild foot block, or sciatic nerve block (30mL of 7.5% ropivacaine for each block). "
11/01/2010 - "Forty ambulatory patients who underwent chevron osteotomy for hallux valgus were randomized to receive perisciatic infusion of ropivacaine 2 mg/ml at a rate of either 5 ml/h (5 ml group) or 8 ml/h (8 ml group). "
11/01/2010 - "Perisciatic infusion of ropivacaine and analgesia after hallux valgus repair."
09/01/2004 - "In 60 patients receiving elective hallux valgus repair, we compared the efficacy of continuous popliteal sciatic nerve block produced with 0.2% ropivacaine (n = 20), 0.2% levobupivacaine (n = 20), or 0.125% levobupivacaine (n = 20) infused with a patient-controlled system starting 3 h after a 30-mL bolus of the 0.5% concentration of the study drug and for 48 h (baseline infusion rate, 6 mL/h; incremental dose, 2 mL; lockout time, 15 min; maximum incremental doses per hour, 3). "
|1.||Bupivacaine (Bupivacaine Hydrochloride)
|2.||Morphine (MS Contin)
|7.||Clonidine (ST 155)
|9.||Opioid Analgesics (Opioids)